SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Cars.com
CARS
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
DSX Diana Shipping
- 1.880
- 0.0000.00%
Trading Dec 26 13:00 ET
235.35MMarket Cap37.60P/E (TTM)
1.900High1.860Low341.91KVolume1.870Open1.880Pre Close641.81KTurnover0.60%Turnover Ratio4.48P/E (Static)125.19MShares3.02552wk High0.47P/B106.45MFloat Cap1.72152wk Low0.38Dividend TTM56.62MShs Float23.456Historical High19.95%Div YieldTTM2.13%Amplitude0.810Historical Low1.877Avg Price1Lot Size
Diana Shipping Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -55.70%70.38M | 77.09%158.86M | 420.51%89.71M | -65.45%17.23M | -37.59%49.88M | |||||
| Net income from continuing operations | -58.14%49.84M | ---- | 107.45%119.06M | 142.77%57.39M | -1,173.82%-134.2M | ---- | ---- | ---- | ---- | -163.54%-10.54M |
| Operating gains losses | -103.12%-7.75M | ---- | 75.17%-3.82M | -962.77%-15.37M | -77.06%1.78M | ---- | ---- | ---- | ---- | 444.08%7.76M |
| Other non cash items | 47.17%56.7M | ---- | -14.89%38.53M | 1.85%45.27M | -15.15%44.45M | ---- | ---- | ---- | ---- | 0.41%52.38M |
| Change In working capital | -616.80%-25.6M | ---- | 134.85%4.95M | 160.69%2.11M | 105.90%809K | ---- | ---- | ---- | ---- | -240.59%-13.72M |
| -Change in receivables | 100.15%4K | ---- | -277.98%-2.69M | 3.99%1.51M | 129.45%1.45M | ---- | ---- | ---- | ---- | -342.96%-4.94M |
| -Change in inventory | -128.90%-511K | ---- | 211.83%1.77M | -295.43%-1.58M | 161.81%809K | ---- | ---- | ---- | ---- | 575.38%309K |
| -Change in prepaid assets | -54.15%-1.95M | ---- | -171.92%-1.27M | -10.57%1.76M | 169.11%1.97M | ---- | ---- | ---- | ---- | -137.76%-2.85M |
| -Change in payables and accrued expense | -128.72%-1.54M | ---- | 532.42%5.35M | 66.08%-1.24M | -93.47%-3.65M | ---- | ---- | ---- | ---- | -123.10%-1.89M |
| -Change in other current assets | -111,437.50%-17.85M | ---- | 98.64%-16K | -367.06%-1.18M | 91.43%-252K | ---- | ---- | ---- | ---- | ---2.94M |
| -Change in other current liabilities | 300.46%437K | ---- | -282.46%-218K | -133.93%-57K | 17.48%168K | ---- | ---- | ---- | ---- | 342.37%143K |
| -Change in other working capital | -307.06%-4.2M | ---- | -29.90%2.03M | 832.26%2.89M | 119.90%310K | ---- | ---- | ---- | ---- | -276.44%-1.56M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -55.70%70.38M | --19.36M | 77.09%158.86M | 420.51%89.71M | -65.45%17.23M | --5.93M | -103.73%-430K | -70.01%4.45M | -59.77%7.29M | -37.59%49.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 109.13%24.93M | -2,143.68%-273.1M | 27.46%13.36M | -72.70%10.48M | -61.36%38.4M | |||||
| Net PPE purchase and sale | 102.13%4.82M | ---- | -1,637.50%-226.6M | 55.40%14.74M | -75.30%9.48M | ---- | ---- | ---- | ---- | 226.70%38.4M |
| Net business purchase and sale | ---771K | ---- | --0 | -175.00%-1.38M | ---500K | ---- | ---- | ---- | ---- | --0 |
| Net investment purchase and sale | 91.19%-4.1M | ---- | ---46.5M | --0 | --1.5M | ---- | ---- | ---- | ---- | --0 |
| Net other investing changes | --24.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 109.13%24.93M | --16.52M | -2,143.68%-273.1M | 27.46%13.36M | -72.70%10.48M | ---1.11M | 13.21%13.86M | -106.42%-1.1M | -138.80%-1.16M | -61.36%38.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -183.82%-71.15M | 243.40%84.88M | 19.03%-59.19M | 34.38%-73.1M | -18.89%-111.4M | |||||
| Net issuance payments of debt | -112.85%-22.15M | ---- | 2,024.73%172.29M | 114.81%8.11M | 3.17%-54.76M | ---- | ---- | ---- | ---- | 19.14%-56.55M |
| Net common stock issuance | -105.39%-79K | ---- | 103.23%1.47M | -278.11%-45.37M | 75.85%-12M | ---- | ---- | ---- | ---- | -227.76%-49.68M |
| Net preferred stock issuance | --0 | ---- | --0 | --254K | --0 | ---- | ---- | ---- | ---- | --960K |
| Cash dividends paid | 44.85%-47.2M | ---- | -486.61%-85.58M | -152.89%-14.59M | 0.00%-5.77M | ---- | ---- | ---- | ---- | 0.00%-5.77M |
| Net other financing activities | 47.79%-1.72M | ---- | 56.52%-3.3M | -1,239.33%-7.59M | -58.82%-567K | ---- | ---- | ---- | ---- | 87.40%-357K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -183.82%-71.15M | --38.56M | 243.40%84.88M | 19.03%-59.19M | 34.38%-73.1M | ---12.29M | -30.78%-24.74M | 46.26%-12.86M | 35.65%-23.21M | -18.89%-111.4M |
| Net cash flow | ||||||||||
| Beginning cash position | -23.16%97.43M | ---- | 52.92%126.79M | -35.37%82.91M | -15.27%128.29M | ---- | ---- | ---- | ---- | 130.07%151.41M |
| Current changes in cash | 182.30%24.16M | ---- | -166.91%-29.36M | 196.69%43.88M | -96.28%-45.38M | ---- | ---- | ---- | ---- | -127.01%-23.12M |
| End cash Position | 24.80%121.59M | ---- | -23.16%97.43M | 52.92%126.79M | -35.37%82.91M | ---- | ---- | ---- | ---- | -15.27%128.29M |
| Free cash flow | 153.59%38.64M | --19.36M | -201.98%-72.11M | 537.33%70.71M | -76.37%11.1M | ---212K | -103.73%-430K | -70.01%4.45M | -59.77%7.29M | -39.11%46.95M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion |
